SCHEMBL14161970

SCHEMBL14161970

Cc1cnc(NCC2CC(c3ccccc3)=NO2)nc1Nc1cc(C2CC2)n[nH]1

nearest known ligand 0.48

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 15/20 0.48
NTRK1 P04629 3/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11938788 0.83 IGF1R (0.45) IGF1RNTRK1
SCHEMBL12439398 0.81 IGF1R (0.53) IGF1R
SCHEMBL14050575 0.80 IGF1R (0.53) IGF1R
SCHEMBL11338826 0.79 IGF1R (0.74) IGF1R
SCHEMBL12439783 0.79 IGF1R (0.51) IGF1R
SCHEMBL12438554 0.79 IGF1R (0.49) IGF1RNTRK1
SCHEMBL14161981 0.77 IGF1R (0.53) IGF1R
SCHEMBL14161988 0.76 IGF1R (0.67) IGF1RNTRK1
SCHEMBL12439767 0.75 IGF1R (0.58) IGF1R
SCHEMBL11343050 0.73 IGF1R (0.70) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008076415-A1 METHODS OF USING MEK INHIBITORS EXELIXIS, INC. (US) 2008-06-26 WO disclosed
WO-2008005538-A2 METHODS OF USING IGF1R AND ABL KINASE MODULATORS EXELIXIS, INC. (US) 2008-01-10 WO disclosed